Skip to main content

2023 SSO Annual Meeting Main banner

Tweets by 2023 SSO Annual Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Speaker

Browse by Speaker

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

V
Vaidya, Anil

Cleveland Clinic
Multivisceral Transplant for PMP
Location:Ballroom C
Anil Vaidya
Valdivieso, Sebastian

Columbia University College of Physicians and Surgeons
21: Organ Preservation, Compliance and Toxicity in Rectal Cancer Patients Treated with Total Neoadjuvant Therapy: A Post Hoc Analysis of the of the OPRA Phase II Trial
Location:Ballroom C
Sebastian Valdivieso
Valero, Vincente

MD Anderson Cancer Center
7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses
Location:Veterans Memorial Auditorium
Vincente Valero
Vallacchi, Viviana

Fondazione IRCCS Istituto Nazionale Tumori
P58: Immune infiltrate of primary retroperitoneal sarcomas (RPS): a prognostic study
Location:SSO HUB: Melanoma & Sarcoma Zone
Viviana Vallacchi
van Akkooi, Alexander

Melanoma Institute Australia, Faculty of Medicine and Health, University of Sydney and Royal Prince Alfred Hospital
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Alexander van Akkooi
Van Buren, George

Baylor College of Medicine
45: Differential Immune Signatures are Associated with Racial Disparities in Pancreatic Cancer
Location:Ballroom A
George Van Buren
van Ramshorst, Gabrielle

Ghent University Hospital
Multidisciplinary Management of Cancer Globally
Location:Room 302
Gabrielle van Ramshorst
Van Zee, Kimberly

Memorial Sloan Kettering Cancer Center
1: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)
Location:Veterans Memorial Auditorium
Kimberly Van Zee
Vandenberg, Jonathan

Mayo Clinic in Florida, Department of Surgery, Jacksonville, FL, USA
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Jonathan Vandenberg
VanderWalde, Ari

West Cancer Center and Research Institute
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Ari VanderWalde
Vardhana, Santosh

Memorial Sloan Kettering Cancer Center
93: Effectiveness of Sentinel Lymph Node Mapping in Gastric Cancer
Location:Ballroom A
Santosh Vardhana
Varey, Alexander

Melanoma Institute Australia; Department of Plastic Surgery, Westmead Hospital; Faculty of Medicine and Health, The University of Sydney
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
Alexander Varey
P44: A Tool For Predicting The Risk Of Death From Melanoma And Competing Causes At Varying Time Intervals After Diagnosis
Location:SSO HUB: Melanoma & Sarcoma Zone
Alexander Varey
Varley, Patrick

Division of Surgical Oncology, Department of Surgery, University of Wisconsin–Madison
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Patrick Varley
Vasigh, Mahtab

Fox Chase Cancer Center
14: Should patients with HR+HER2- breast cancer and 1-3 positive sentinel nodes undergo axillary dissection to determine candidacy for abemaciclib?
Location:Veterans Memorial Auditorium
Mahtab Vasigh
Vauthey, Jean-Nicolas

The University of Texas MD Anderson Cancer Center
36: KRAS-G12V and TP53 But Not KRAS-G12V Mutation Alone Is Associated with Worse Survival in Patients with Resected Colorectal Liver Metastasis
Location:Veterans Memorial Auditorium
Jean-Nicolas Vauthey
Meet the Experts - HPB Malignancies
Location:Ballroom A
Jean-Nicolas Vauthey
Vemuru, Sudheer

University of Colorado Anschutz Medical Center
P9: Comparing Patient Reported Outcomes for Same-day Discharge and Inpatient Admission After Mastectomy
Location:SSO HUB: Breast & Endocrine Zone
Sudheer Vemuru
Venkatramani, Mandakini

Northshore University HealthSystems
33: Validated Predictive Model for Prognosis and Treatment of Papillary Thyroid Carcinoma
Location:Ballroom A
Mandakini Venkatramani
Verbus, Emily

National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Emily Verbus
Verhagen, Nathaniel

Medical College of Wisconsin
87: Identifying Optimal Surgical Timing Relative to SARS-CoV-2 Infection Using COVID-19 Severity in Cancer Patients
Location:Ballroom B
Nathaniel Verhagen
Verheij, Floris

Netherlands Cancer Institute
21: Organ Preservation, Compliance and Toxicity in Rectal Cancer Patients Treated with Total Neoadjuvant Therapy: A Post Hoc Analysis of the of the OPRA Phase II Trial
Location:Ballroom C
Floris Verheij
Vickers, Selwyn

University of Alabama at Birmingham
John Wayne Clinical Research Lecture: "Opportunities and Challenges of Clinical Trials in Addressing Cancer Health Disparities"
Location:Veterans Memorial Auditorium
Selwyn Vickers
Vidri, Roberto

University of Wisconsin School of Medicine and Public Health
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Roberto Vidri
Vierkant, Robert

Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic
P28: Hurthle cell carcinoma - Is a hemithyroidectomy enough?
Location:SSO HUB: Breast & Endocrine Zone
Robert Vierkant
Vigneshwar, Navin

University of Colorado School of Medicine, Department of Surgery
P77: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Navin Vigneshwar
VIllano, Anthony

Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, USA
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Anthony VIllano
Vingan, Perri

Memorial Sloan Kettering
19: Sexual Well-being in Patients with Breast Cancer Surgery: Trends, Associated Factors, and Interventions.
Location:Veterans Memorial Auditorium
Perri Vingan
Vita, Ann

Providence Saint John's Cancer Institute
81: Racial and socioeconomic disparities in colorectal cancer screening during the COVID-19 pandemic
Location:Ballroom B
Ann Vita
Votanopoulos, Konstantinos

Wake Forest University
66: Utilizing Organoids to Study Perfusate Selection in Appendiceal Cancer Patients Undergoing Repeat HIPEC
Location:Ballroom B
Konstantinos Votanopoulos
68: Assessing the Mucolytic and Cytotoxic Activity of Bromelain in Appendiceal Cancer Organoids
Location:Ballroom B
Konstantinos Votanopoulos
Vreeland, Timothy

San Antonio Military Medical Center
P75: “Next Gen” Operative Notes – synoptic operative reporting for cancer surgery
Location:SSO HUB: Rare/Metastatic Cancers Zone
Timothy Vreeland
Vrochides, Dionisios

Atrium Health Carolinas Medical Center
47: Surgical Microwave Ablation for Treatment of Hepatocellular Carcinoma: A Single Institution Review from 2006-2022
Location:Ballroom A
Dionisios Vrochides